The use of atypical antipsychotics in the management of schizophrenia. (Q33540449)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

The use of atypical antipsychotics in the management of schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

author name string

M Campbell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

P I Young

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

J M Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

S H Thomas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

British Journal of Clinical Pharmacology

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

13-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

Measuring quality of life in patients with schizophrenia

11 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014208

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014208

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014208

Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014208

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014208

Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014208

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014208

Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014208

Pitfalls and problems of the long term use of neuroleptic drugs in schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014208

Schizophrenia: developmental neuroscience and pathobiology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014208

An update on the epidemiology of schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014208

Education for educating surgeons

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046/J.1365-2125.1999.00849.X

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046/J.1365-2125.1999.00849.X

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046/J.1365-2125.1999.00849.X

Risperidone-induced neuroleptic malignant syndrome

21 January 2018

1 reference

12 December 2020

Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia

1 reference

12 December 2020

1 reference

12 December 2020

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

12 December 2020

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1 reference

12 December 2020

A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia

1 reference

12 December 2020

Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone

1 reference

12 December 2020

Economic and Health State Utility Determinations for Schizophrenic Patients Treated With Risperidone or Haloperidol

1 reference

12 December 2020

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

12 December 2020

Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol

1 reference

12 December 2020

Cost-effectiveness of clozapine. A UK clinic-based study

1 reference

12 December 2020

10.1046/J.1365-2125.1999.00849.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073734 AND SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

10073734

1 reference